For decades, clinical trials have been the engine that has driven our field forward. At every phase, they have delivered incredible discoveries, changed our practice, opened new avenues of investigation, given patients the opportunity to access novel agents, and most importantly, brought hope to our patients and their loved ones. But even as they represent...
By Narjust Florez, MD, Fatima Wilder, MD, MSc, Lauren Kiel, BS, and Rebekah Kaufman, MSIt is about time that we change the narrative of lung cancer being a disease that impacts elderly men with a smoking history into one that encompasses our modern reality of an inclusive patient population, including women and especially including...
Researcher Spotlight Home » Erin Parry, MD, PhD Researcher Spotlight: Erin Parry, MD, PhD DANA-FARBER CANCER INSTITUTE Dr. Parry’s research is centered at the intersection of genomics and cancer immunotherapy, with a focus on B cell lymphomas. Her LRF research project is aimed at understanding...
Researcher Spotlight Home » Wen-Hsuan Wendy Lin, MD, PhD Researcher Spotlight: Wen-Hsuan Wendy Lin, MD, PhD COLUMBIA UNIVERSITY Peripheral T-cell lymphomas (PTCL) represent a group of aggressive blood cancers with poor outcomes. A common phenomenon in PTCL is the development of a proinflammatory microenvironment, in...
Researcher Spotlight Home » Andrew Jallouk, MD, PhD Researcher Spotlight: Andrew Jallouk, MD, PhD VANDERBILT UNIVERSITY MEDICAL CENTER Errol M. Cook Memorial Scholar Chimeric antigen receptor (CAR) T-cell therapy represents a highly effective treatment option for many types of lymphoma. Currently available CAR T-cell therapies are...
Time Management Tips
13.6 ° C